Yiheng Capital Management, L.P.

Position in PASG — Passage BIO, Inc.

CIK 1447228 SAN FRANCISCO, CA

Position in PASG

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$420,153

-$255,708 QoQ

Shares Held

86,097

0.0% QoQ

Ownership

2.68%

of shares outstanding

% of Portfolio

0.18%

of 13F equity value

Holder Rank

of 30 holders

Holding Since

Dec 2025

3 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Yiheng Capital Management, L.P. holds $18,566,712 across 5 Biotechnology names. PASG ranks #5 (2.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRDN	Viridian Therapeutics, Inc.\DE	400,464	$7,356,523
2	KYMR	Kymera Therapeutics, Inc.	63,440	$7,274,664
3	DBVT	DBV Technologies S.A.	170,142	$2,790,328
4	BEAM	Beam Therapeutics Inc.	21,126	$725,044
5	PASG	Passage BIO, Inc. This page	86,097	$420,153

3 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$420,153	86,097	0.0%	Shares	Sole	2026-08-14
2026-03-31	$675,861	86,097	+151.0%	Shares	Sole	2026-05-15
2025-12-31	$404,751	34,301	—	Shares	Sole	2026-02-17
No filing history on record for this holder in this stock.